What did @rissiriss87 actually say?
The creator says Thymosin Alpha-1 is now her top peptide, replacing NAD, because it gave her "the perfect amount of energy and calmness and happiness." She also claims it is "looked at for immune function and support, mood regulation and showing some benefits for things like depression." She frames this as personal research, not medical advice.
To be fair, she is transparent about what she is doing. The "this is my research" disclaimer is there, and she is not selling anything in this clip. But 21,000 people are watching someone describe a mood lift from a peptide that has almost no human data for that use case. The disclaimer does not change what the audience hears, which is: this peptide made me happier and calmer, and you should look into it.
Does the science back this up?
For immune function, yes, there is actual clinical evidence. For mood, energy, and depression, the evidence is thin to nonexistent in humans.
Thymosin Alpha-1 (Ta1) is a synthetic version of a naturally occurring thymic peptide. It is approved in several countries outside the US under the brand name Zadaxin for hepatitis B, hepatitis C, and as an immune adjuvant in certain cancers. That is a real regulatory approval backed by real trials. Romani et al. (2012, Expert Opinion on Biological Therapy) summarized its immunomodulatory mechanism well: Ta1 activates dendritic cells and T-helper cells via Toll-like receptors, which is a legitimate pathway.
The mood and depression angle is where things fall apart. There are animal studies suggesting neuroimmune interactions that could affect behavior, but a PubMed search returns no randomized controlled trials in humans testing Ta1 for depression, mood regulation, or energy. The creator is citing a research direction, not a research result. That is a meaningful difference.
What did they get wrong (or right)?
She got the immune function framing mostly right. She got the mood and depression framing wrong, or at least premature.
Calling NAD a "peptide" is also incorrect. NAD (nicotinamide adenine dinucleotide) is a coenzyme, not a peptide. It is a common conflation in the research peptide community, but it is worth naming. Peptides are short chains of amino acids. NAD is not.
The "nobody is talking about this" framing also deserves skepticism. Ta1 has been researched since the 1980s. Goldstein et al. described its isolation from thymic tissue back in 1977 (Science). It is not obscure in immunology. It is obscure in the wellness-peptide TikTok space, which is a different thing.
She does not make dosing claims, does not name a supplier, and does not claim it cures anything specific. That is genuinely better than most peptide content on the platform. Credit where it is due.
What should you actually know?
Thymosin Alpha-1 is one of the more studied peptides in the immune space, but its human evidence is almost entirely in the context of serious illness, not optimization or mood.
The trials that exist enrolled patients with hepatitis, HIV, or cancer, not healthy people looking for energy and calm. Lo et al. (2008, Clinical Infectious Diseases) found Ta1 improved immune outcomes in sepsis patients, which is a very different population than a healthy person self-experimenting on TikTok. Extrapolating from sepsis immunology to "I feel amazing" is a long leap.
There is also a procurement issue that the video does not address. In the US, Thymosin Alpha-1 is not FDA-approved for any indication. It exists in a gray market as a research chemical. Purity, concentration, and sterility of gray-market peptides are not guaranteed. That is a real risk that a 21,000-view video probably should mention.
If you are curious about peptide therapy for immune support, that is a conversation worth having with a licensed clinician who can review your actual health status, not a TikTok comment section.